Qi Hui

Qi-Hui Bio, officially known as Beijing Qi-hui Biopharmaceutical Co., Ltd., is a medical technology company specializing in the development of advanced ultrasound diagnosis and treatment solutions. Founded in 2016 and headquartered in Beijing, the company leverages intelligent ultrasound technology and precise contrast-enhanced ultrasound to create high-end diagnostic equipment. Its core research focus includes the development of lipid microbubble-based ultrasound imaging agents and therapeutic delivery systems. Qi-Hui Bio aims to provide medical professionals with reliable, high-quality diagnostic tools and customized services based on image data. The company is currently in the early stages of developing its nanotechnology-enabled medical device pipeline, primarily targeting oncology and cardiovascular indications.